<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="23/05/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9882624" creator="Noriko Katsu">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>9882624</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Mildly <term sem="Protein_family_or_group" id="A12">oxidized <term sem="Protein_family_or_group" id="T1" lex="low-density_lipoprotein">low-density lipoproteins</term></term> decrease early production of <term sem="Protein_molecule" id="T2" lex="interleukin_2">interleukin 2</term> and <term sem="Protein_complex" id="T3" lex="nuclear_factor_kappaB">nuclear factor kappaB</term> binding to <term sem="DNA_domain_or_region" id="A1">DNA</term> in <term sem="Cell_natural" id="T4" lex="activated_T-lymphocyte">activated <term sem="Cell_natural" id="A2">T-lymphocytes</term></term>.</sentence>
<event id="E1">
<type class="Negative_regulation" />
<theme idref="E3" />
<cause idref="A12" />
<clue>Mildly oxidized low-density lipoproteins <clueType>decrease</clueType> early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes.</clue>
</event>
<event id="E2">
<type class="Negative_regulation" />
<theme idref="E4" />
<cause idref="A12" />
<clue>Mildly oxidized low-density lipoproteins <clueType>decrease</clueType> early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes.</clue>
</event>
<event id="E3">
<type class="Gene_expression" />
<theme idref="T2" />
<clue>Mildly oxidized low-density lipoproteins decrease <clueTime>early</clueTime> <clueType>production</clueType> <linkTheme>of</linkTheme> interleukin 2 and nuclear factor kappaB binding to DNA <clueLoc>in activated T-lymphocytes</clueLoc>.</clue>
</event>
<event id="E4">
<type class="Binding" />
<theme idref="T3" />
<theme idref="A1" />
<clue>Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB <clueType>binding</clueType> <linkTheme>to</linkTheme> DNA <clueLoc>in activated T-lymphocytes</clueLoc>.</clue>
</event>
<event id="E5">
<type class="Physiological_process" />
<theme idref="A2" />
<clue>Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in <clueType>activated</clueType> T-lymphocytes.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Activated <term sem="Cell_natural" id="A3">T-lymphocytes</term> are found early in <term sem="Tissue_natural" id="T5" lex="atherosclerosis_lesion">atherosclerosis lesions</term>, but little is known about their role.</sentence>
<event id="E6">
<type class="Physiological_process" />
<theme idref="A3" />
<clue><clueType>Activated</clueType> T-lymphocytes are found <clueTime>early</clueTime> <clueLoc>in atherosclerosis lesions</clueLoc>, but little is known about their role.</clue>
</event>
<sentence id="S3">Oxidized <term sem="Protein_family_or_group" id="T6" lex="low-density_lipoprotein">low-density lipoproteins</term> (<term sem="Protein_family_or_group" id="T7" lex="oxLDL">oxLDLs</term>) are considered to be involved in the pathogenesis of the lesions, and we have previously demonstrated that <term sem="Protein_family_or_group" id="T8" lex="oxLDL">oxLDLs</term> inhibit not only <term sem="Other" id="T9" lex="interleukin_(IL)-2-receptor_expression"><term sem="Protein_molecule" id="T10" lex="interleukin_(IL)-2-receptor">interleukin (IL)-2-receptor</term> expression</term> on the surface of in vitro-<term sem="Cell_natural" id="A13">activated <term sem="Cell_natural" id="A4">T-lymphocytes</term></term> but also their proliferation.</sentence>
<event id="E7">
<type class="Regulation" />
<theme idref="E40" />
<cause idref="T7" />
<clue>Oxidized low-density lipoproteins (oxLDLs) are considered to be <clueType>involved</clueType> <linkTheme>in</linkTheme> the pathogenesis of the lesions, and we have previously demonstrated that oxLDLs inhibit not only interleukin (IL)-2-receptor expression on the surface of in vitro-activated T-lymphocytes but also their proliferation.</clue>
</event>
<event id="E40">
<type />
<theme idref="T5" />
<clue>Oxidized low-density lipoproteins (oxLDLs) are considered to be involved in the <clueType>pathogenesis</clueType> <linkTheme>of</linkTheme> <corefTheme>the lesions</corefTheme>, and we have previously demonstrated that oxLDLs inhibit not only interleukin (IL)-2-receptor expression on the surface of in vitro-activated T-lymphocytes but also their proliferation.</clue>
<comment>SOO</comment>
</event>
<event id="E8">
<type class="Negative_regulation" />
<theme idref="E10" />
<cause idref="T8" />
<clue>Oxidized low-density lipoproteins (oxLDLs) are considered to be involved in the pathogenesis of the lesions, and we have previously demonstrated that oxLDLs <clueType>inhibit</clueType> not only interleukin (IL)-2-receptor expression on the surface of in vitro-activated T-lymphocytes but also their proliferation.</clue>
</event>
<event id="E9">
<type class="Negative_regulation" />
<theme idref="E11" />
<cause idref="T8" />
<clue>Oxidized low-density lipoproteins (oxLDLs) are considered to be involved in the pathogenesis of the lesions, and we have previously demonstrated that oxLDLs <clueType>inhibit</clueType> not only interleukin (IL)-2-receptor expression on the surface of in vitro-activated T-lymphocytes but also their proliferation.</clue>
</event>
<event id="E10">
<type class="Gene_expression" />
<theme idref="T10" />
<clue>Oxidized low-density lipoproteins (oxLDLs) are considered to be involved in the pathogenesis of the lesions, and we have previously demonstrated that oxLDLs inhibit not only interleukin (IL)-2-receptor <clueType>expression</clueType> <clueLoc>on the surface of in vitro-activated T-lymphocytes</clueLoc> but also their proliferation.</clue>
</event>
<event id="E11">
<type class="Cellular_physiological_process" />
<theme idref="A13" />
<clue>Oxidized low-density lipoproteins (oxLDLs) are considered to be involved in the pathogenesis of the lesions, and we have previously demonstrated that oxLDLs inhibit not only interleukin (IL)-2-receptor expression on the surface of in vitro-activated T-lymphocytes but also <corefTheme>their</corefTheme> <clueType>proliferation</clueType>.</clue>
</event>
<event id="E12">
<type class="Physiological_process" />
<theme idref="A4" />
<clue>Oxidized low-density lipoproteins (oxLDLs) are considered to be involved in the pathogenesis of the lesions, and we have previously demonstrated that oxLDLs inhibit not only interleukin (IL)-2-receptor expression on the surface of in vitro-<clueType>activated</clueType> T-lymphocytes but also their proliferation.</clue>
</event>
<sentence id="S4">We have now investigated the effect of <term sem="Protein_family_or_group" id="T11" lex="oxLDL">oxLDLs</term> on <term sem="Other" id="T12" lex="blast_differentiation">blast differentiation</term>, on <term sem="Other" id="T13" lex="IL-2_synthesis"><term sem="Protein_molecule" id="T14" lex="IL-2">IL-2</term> synthesis</term> and on the activation of the <term sem="Other" id="T15" lex="nuclear_factor_kappaB_(NF-kappaB)_system"><term sem="Protein_complex" id="T16" lex="nuclear_factor_kappaB">nuclear factor kappaB</term> (<term sem="Protein_complex" id="T17" lex="NF-kappaB">NF-kappaB</term>) system</term> in activated <term sem="Cell_natural" id="A5">lymphocytes</term>.</sentence>
<event uncertainty="doubtful" id="E13">
<type class="Regulation" />
<theme idref="T12" />
<cause idref="T11" />
<clue>We have now investigated the <clueType>effect</clueType> <linkCause>of</linkCause> oxLDLs <linkTheme>on</linkTheme> blast differentiation, on IL-2 synthesis and on the activation of the nuclear factor kappaB (NF-kappaB) system <clueLoc>in activated lymphocytes</clueLoc>.</clue>
</event>
<event uncertainty="doubtful" id="E14">
<type class="Regulation" />
<theme idref="E16" />
<cause idref="T11" />
<clue>We have now investigated the <clueType>effect</clueType> <linkCause>of</linkCause> oxLDLs on blast differentiation, <linkTheme>on</linkTheme> IL-2 synthesis and on the activation of the nuclear factor kappaB (NF-kappaB) system in activated lymphocytes.</clue>
</event>
<event uncertainty="doubtful" id="E15">
<type class="Regulation" />
<theme idref="E17" />
<cause idref="T11" />
<clue>We have now investigated the <clueType>effect</clueType> <linkCause>of</linkCause> oxLDLs on blast differentiation, on IL-2 synthesis and <linkTheme>on</linkTheme> the activation of the nuclear factor kappaB (NF-kappaB) system in activated lymphocytes.</clue>
</event>
<event id="E16">
<type class="Gene_expression" />
<theme idref="T14" />
<clue>We have now investigated the effect of oxLDLs on blast differentiation, on IL-2 <clueType>synthesis</clueType> and on the activation of the nuclear factor kappaB (NF-kappaB) system <clueLoc>in activated lymphocytes</clueLoc>.</clue>
</event>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="T17" />
<clue>We have now investigated the effect of oxLDLs on blast differentiation, on IL-2 synthesis and on the <clueType>activation</clueType> <linkTheme>of</linkTheme> the nuclear factor kappaB (NF-kappaB) system <clueLoc>in activated lymphocytes</clueLoc>.</clue>
</event>
<event id="E18">
<type class="Physiological_process" />
<theme idref="A5" />
<clue>We have now investigated the effect of oxLDLs on blast differentiation, on IL-2 synthesis and on the activation of the nuclear factor kappaB (NF-kappaB) system in <clueType>activated</clueType> lymphocytes.</clue>
</event>
<sentence id="S5">Mildly <term sem="Protein_family_or_group" id="T18" lex="oxLDL">oxLDLs</term> (50 and 100 microgram/ml) decreased the number of <term sem="Cell_natural" id="T19" lex="lymphoblast">lymphoblasts</term> and the level of <term sem="Protein_molecule" id="A6">IL-2</term> concentration in the culture supernatants after activation of <term sem="Cell_natural" id="T20" lex="lymphocyte">lymphocytes</term> by <term sem="Protein_molecule" id="T21" lex="phytohaemagglutinin">phytohaemagglutinin</term> and <term sem="Organic_compound_other" id="T22" lex="PMA+ionomycin"><term sem="Organic_compound_other" id="A7">PMA</term>+<term sem="Organic_compound_other" id="T23" lex="ionomycin">ionomycin</term></term>.</sentence>
<event id="E19">
<type class="Negative_regulation" />
<theme idref="T19" />
<cause idref="T18" />
<clue>Mildly oxLDLs (50 and 100 microgram/ml) <clueType>decreased</clueType> the number <linkTheme>of</linkTheme> lymphoblasts and the level of IL-2 concentration in the culture supernatants after activation of lymphocytes by phytohaemagglutinin and PMA+ionomycin.</clue>
</event>
<event id="E20">
<type class="Negative_regulation" />
<theme idref="A6" />
<cause idref="T18" />
<clue>Mildly oxLDLs (50 and 100 microgram/ml) <clueType>decreased</clueType> the number of lymphoblasts and the level <linkTheme>of</linkTheme> IL-2 concentration <clueLoc>in the culture supernatants</clueLoc> after activation of lymphocytes by phytohaemagglutinin and PMA+ionomycin.</clue>
</event>
<event id="E21">
<type class="Physiological_process" />
<theme idref="T20" />
<cause idref="T21" />
<clue>Mildly oxLDLs (50 and 100 microgram/ml) decreased the number of lymphoblasts and the level of IL-2 concentration in the culture supernatants after <clueType>activation</clueType> <linkTheme>of</linkTheme> lymphocytes <linkCause>by</linkCause> phytohaemagglutinin and PMA+ionomycin.</clue>
</event>
<event id="E22">
<type class="Physiological_process" />
<theme idref="T20" />
<cause idref="A7" />
<cause idref="T23" />
<clue>Mildly oxLDLs (50 and 100 microgram/ml) decreased the number of lymphoblasts and the level of IL-2 concentration in the culture supernatants after <clueType>activation</clueType> <linkTheme>of</linkTheme> lymphocytes <linkCause>by</linkCause> phytohaemagglutinin and PMA+ionomycin.</clue>
</event>
<event id="E23">
<type class="Regulation" />
<theme idref="E19" />
<cause idref="E21" />
<clue>Mildly oxLDLs (50 and 100 microgram/ml) decreased the number of lymphoblasts and the level of IL-2 concentration in the culture supernatants <linkCause>after</linkCause> activation of lymphocytes by phytohaemagglutinin and PMA+ionomycin.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E24">
<type class="Regulation" />
<theme idref="E20" />
<cause idref="E21" />
<clue>Mildly oxLDLs (50 and 100 microgram/ml) decreased the number of lymphoblasts and the level of IL-2 concentration in the culture supernatants <linkCause>after</linkCause> activation of lymphocytes by phytohaemagglutinin and PMA+ionomycin.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E25">
<type class="Regulation" />
<theme idref="E19" />
<cause idref="E22" />
<clue>Mildly oxLDLs (50 and 100 microgram/ml) decreased the number of lymphoblasts and the level of IL-2 concentration in the culture supernatants <linkCause>after</linkCause> activation of lymphocytes by phytohaemagglutinin and PMA+ionomycin.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event id="E26">
<type class="Regulation" />
<theme idref="E20" />
<cause idref="E22" />
<clue>Mildly oxLDLs (50 and 100 microgram/ml) decreased the number of lymphoblasts and the level of IL-2 concentration in the culture supernatants <linkCause>after</linkCause> activation of lymphocytes by phytohaemagglutinin and PMA+ionomycin.</clue>
<comment>NO CLUETYPE</comment>
</event>
<sentence id="S6">The inhibition of <term sem="Protein_molecule" id="T24" lex="IL-2">IL-2</term> production was observed in the <term sem="Cell_component" id="T25" lex="CD3(+)_T-lymphocyte_cytoplasm"><term sem="Protein_molecule" id="T26" lex="CD3">CD3</term>(+) <term sem="Cell_natural" id="A8">T-lymphocyte</term> cytoplasm</term> as early as 4 h after activation by <term sem="Organic_compound_other" id="T27" lex="PMA+ionomycin"><term sem="Organic_compound_other" id="A9">PMA</term>+<term sem="Organic_compound_other" id="T28" lex="ionomycin">ionomycin</term></term>.</sentence>
<event id="E27">
<type class="Negative_regulation" />
<theme idref="E28" />
<cause idref="E29" />
<clue>The <clueType>inhibition</clueType> <linkTheme>of</linkTheme> IL-2 production was observed <clueLoc>in the CD3(+) T-lymphocyte cytoplasm</clueLoc> <clueTime>as early as 4 h</clueTime> <linkCause>after</linkCause> activation by PMA+ionomycin.</clue>
</event>
<event id="E28">
<type class="Gene_expression" />
<theme idref="T24" />
<clue>The inhibition of IL-2 <clueType>production</clueType> was observed in the CD3(+) T-lymphocyte cytoplasm as early as 4 h after activation by PMA+ionomycin.</clue>
</event>
<event id="E29">
<type class="Physiological_process" />
<theme idref="A8" />
<cause idref="A9" />
<cause idref="T28" />
<clue>The inhibition of IL-2 production was observed in the CD3(+) T-lymphocyte cytoplasm as early as 4 h after <clueType>activation</clueType> <linkCause>by</linkCause> PMA+ionomycin.</clue>
</event>
<sentence id="S7">The study of <term sem="Protein_complex" id="T29" lex="NF-kappaB">NF-kappaB</term> showed that <term sem="Protein_family_or_group" id="T30" lex="oxLDL">oxLDLs</term> led to a decrease of activation-induced <term sem="Protein_complex" id="A14"><term sem="Protein_molecule" id="A10">p65</term>/<term sem="Protein_molecule" id="T32" lex="p50">p50</term> <term sem="Protein_complex" id="T33" lex="NF-kappaB">NF-kappaB</term> heterodimer</term> binding to <term sem="DNA_domain_or_region" id="A11">DNA</term>, whereas the presence of the constitutive nuclear form of <term sem="Protein_complex" id="T34" lex="p50_dimer"><term sem="Protein_molecule" id="T35" lex="p50">p50</term> dimer</term> was unchanged.</sentence>
<event id="E31">
<type class="Negative_regulation" />
<theme idref="E34" />
<cause idref="T30" />
<clue>The study of NF-kappaB showed that oxLDLs led to a <clueType>decrease</clueType> <linkTheme>of</linkTheme> activation-induced p65/p50 NF-kappaB heterodimer binding to DNA, whereas the presence of the constitutive nuclear form of p50 dimer was unchanged.</clue>
</event>
<event id="E32">
<type class="Binding" />
<theme idref="A14" />
<theme idref="A11" />
<clue>The study of NF-kappaB showed that oxLDLs led to a decrease of activation-induced p65/p50 NF-kappaB heterodimer <clueType>binding</clueType> <linkTheme>to</linkTheme> DNA, whereas the presence of the constitutive nuclear form of p50 dimer was unchanged.</clue>
</event>
<event id="E34">
<type class="Positive_regulation" />
<theme idref="E32" />
<cause idref="E29" />
<clue>The study of NF-kappaB showed that oxLDLs led to a decrease of <corefCause>activation</corefCause>-<clueType>induced</clueType> p65/p50 NF-kappaB heterodimer binding to DNA, whereas the presence of the constitutive nuclear form of p50 dimer was unchanged.</clue>
<comment>NER: T31 del &quot;activation-induced p65/ p50&quot;</comment>
</event>
<event assertion="non-exist" id="E35">
<type class="Negative_regulation" />
<theme idref="T34" />
<clue>The study of NF-kappaB showed that oxLDLs led to a decrease of activation-induced p65/p50 NF-kappaB heterodimer binding to DNA, whereas the presence of the constitutive <clueLoc>nuclear</clueLoc> form of p50 dimer was <clueType>unchanged</clueType>.</clue>
</event>
<sentence id="S8">This was correlated with an unchanged level of the active form of the <term sem="Protein_family_or_group" id="T36" lex="cytosolic_inhibitor_protein">cytosolic inhibitor protein</term> <term sem="Protein_molecule" id="T37" lex="IkappaB-alpha">IkappaB-alpha</term>.</sentence>
<event id="E36">
<type class="Correlation" />
<theme idref="E35" />
<theme idref="T37" />
<clue><corefTheme>This</corefTheme> was <clueType>correlated</clueType> <linkTheme>with</linkTheme> an unchanged level of the active form of the <clueLoc>cytosolic</clueLoc> inhibitor protein IkappaB-alpha.</clue>
</event>
<sentence id="S9">Taken together, these observations suggest that the immunosuppressive effect of <term sem="Protein_family_or_group" id="T38" lex="oxLDL">oxLDLs</term> might operate via a <term sem="Other" id="T39" lex="dysregulation">dysregulation</term> of the <term sem="Other" id="T40" lex="T-lymphocyte_activation_mechanisms"><term sem="Cell_natural" id="T41" lex="T-lymphocyte">T-lymphocyte</term> activation mechanisms</term>.</sentence>
<event id="E37">
<type class="Negative_regulation" />
<cause idref="T38" />
<clue>Taken together, these observations suggest that the <clueType>immunosuppressive effect</clueType> <linkCause>of</linkCause> oxLDLs might operate via a dysregulation of the T-lymphocyte activation mechanisms.</clue>
<comment>NO THEME</comment>
</event>
<event id="E38">
<type class="Positive_regulation" />
<theme idref="E39" />
<cause idref="E37" />
<clue>Taken together, these observations suggest that the immunosuppressive effect of oxLDLs <clueType>might operate</clueType> <linkCause>via</linkCause> a dysregulation of the T-lymphocyte activation mechanisms.</clue>
</event>
<event id="E39">
<type class="Regulation" />
<theme idref="T40" />
<clue>Taken together, these observations suggest that the immunosuppressive effect of oxLDLs might operate via a <clueType>dysregulation</clueType> <linkTheme>of</linkTheme> the T-lymphocyte activation mechanisms.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
